Price Alert

Corcept Therapeutics (CORT)

NASDAQ: CORT · Real-Time Price · USD

71.72

-0.28 (-0.39%)

At close: Aug 15, 2025, 3:59 PM

71.75

0.03%

After-hours: Aug 15, 2025, 04:54 PM EDT

Corcept Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	716.08M	685.45M	675.04M	628.55M	569.61M	523.53M	482.38M	450.03M	428.15M	413.82M	401.86M	397.62M	392.03M	380.23M	365.98M	352.89M	343.09M	340.06M
Cost of Revenue	11.66M	10.75M	10.88M	9.8M	8.58M	7.63M	6.48M	6.08M	5.78M	5.52M	5.38M	5.26M	5.2M	5.26M	5.28M	5.18M	5.12M	4.97M
Gross Profit	704.42M	674.7M	664.16M	618.75M	561.03M	515.9M	475.89M	443.94M	422.37M	408.3M	396.47M	392.37M	386.83M	374.97M	360.7M	347.71M	337.96M	335.09M
Operating Income	101.95M	110.87M	136.95M	143.36M	127.94M	121.93M	107.28M	98.11M	98.87M	100.72M	112.63M	126.8M	131.1M	131.61M	124.48M	118.32M	106.81M	110.13M
Interest Income	24.26M	25.25M	24.54M	22.98M	21.84M	19.19M	17.28M	13.91M	9.78M	7.06M	3.56M	1.85M	854K	334K	529K	754K	1.3M	2.2M
Pretax Income	126.21M	136.12M	161.49M	166.34M	149.78M	141.12M	124.56M	112.03M	108.64M	107.78M	116.19M	128.65M	131.95M	131.94M	125.01M	119.08M	108.11M	112.33M
Net Income	132.52M	132.85M	140.33M	141.29M	125.98M	118.02M	106.14M	91.39M	94.62M	94.5M	101.42M	116.87M	112.73M	111.84M	112.51M	106.45M	97.61M	99.41M
Selling & General & Admin	351.63M	314.71M	280.32M	244.1M	215.62M	191.96M	184.26M	179.43M	169.33M	163.86M	152.85M	142.81M	138.18M	130.4M	122.36M	115.77M	111.76M	107.3M
Research & Development	250.84M	249.12M	246.89M	231.29M	217.47M	202.01M	184.35M	166.4M	154.17M	143.72M	130.99M	122.76M	117.56M	112.96M	113.86M	113.62M	119.4M	117.66M
Other Expenses	n/a	500K	500K	500K	500K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	602.47M	563.83M	527.21M	475.39M	433.09M	393.97M	368.61M	345.83M	323.5M	307.58M	283.84M	265.57M	255.74M	243.36M	236.22M	229.39M	231.16M	224.96M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	614.13M	574.58M	538.09M	485.2M	441.67M	401.6M	375.09M	351.91M	329.28M	313.11M	289.22M	270.82M	260.93M	248.62M	241.5M	234.57M	236.28M	229.94M
Income Tax Expense	-7.44M	2.12M	20.28M	24.52M	23.8M	23.09M	18.42M	20.64M	14.03M	13.28M	14.77M	11.78M	19.22M	20.1M	12.49M	12.62M	10.51M	12.92M
Shares Outstanding (Basic)	104.11M	104.11M	103.64M	103.37M	103.12M	102.79M	102.45M	102.01M	101.96M	107.89M	107.7M	115.17M	114.16M	113.98M	113.74M	115.79M	116.29M	116.82M
Shares Outstanding (Diluted)	120.48M	119.82M	118.46M	113.72M	111.24M	109.92M	110.89M	111.1M	109.59M	115.42M	116.33M	116.62M	115.4M	115.04M	122.43M	125.14M	126.68M	129.67M
EPS (Basic)	1.26	1.27	1.35	1.36	1.22	1.15	1.03	0.88	0.87	0.84	0.89	1.02	0.98	0.97	0.97	0.91	0.84	0.86
EPS (Diluted)	1.13	1.16	1.24	1.26	1.13	1.06	0.95	0.81	0.83	0.82	0.88	1.00	0.94	0.91	0.89	0.83	0.76	0.78
EBITDA	103.84M	118.55M	144.29M	150.81M	135.18M	123.22M	108.74M	99.74M	100.96M	103.18M	115.6M	129.82M	134.13M	134.73M	127.54M	121.16M	109.44M	112.51M
EBIT	101.95M	116.87M	142.96M	149.36M	133.94M	121.93M	107.28M	98.11M	98.87M	100.72M	112.63M	126.8M	131.1M	131.61M	124.48M	118.32M	106.81M	110.13M
Depreciation & Amortization	1.89M	1.68M	1.34M	1.45M	1.24M	1.29M	1.46M	1.63M	2.1M	2.46M	2.97M	3.02M	3.04M	3.13M	3.07M	2.83M	2.63M	2.38M